Literature DB >> 3489533

Similarities and distinctions between murine natural killer cells and lymphokine-activated killer cells.

V J Merluzzi, M D Smith, K Last-Barney.   

Abstract

Pretreatment of mice with rabbit anti-asialo GM1 removes both natural killer (NK) effector cells and NK cells responsive to interleukin 2 (IL-2). Spleen cells from these mice do possess normal lymphokine-activated killer (LAK) activity. Young mice (less than 3 weeks of age) do not have NK activity and do not possess IL-2-inducible NK effector cells. Similarly to anti-asialo GM1-treated mice, LAK cells can be generated from these mice. While these experiments indicate clear distinctions between a certain level of NK and LAK precursors, the distinctions are not as clear when analyzing mice congenitally deficient in NK cells. Beige mice which lack NK effector cells and IL-2-inducible NK cells also lack the ability to generate LAK cells. The relationships and differences between NK- and LAK-cell precursors and effectors are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489533     DOI: 10.1016/0008-8749(86)90054-7

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

Review 1.  Cancer therapy with bispecific antibodies: Clinical experience.

Authors:  Archana Thakur; Lawrence G Lum
Journal:  Curr Opin Mol Ther       Date:  2010-06

2.  Induction of activated natural killer cells from murine spleen cells primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.

Authors:  H Yamaue; M Katsumi; K Tabuse; Y Tabuse; K Kuribayashi; T Nishihara; K Saito
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  Amelioration of experimental lung metastasis in mice by therapy with anti-CD3 monoclonal antibodies.

Authors:  D W Hoskin; J Stankova; S K Anderson; J C Roder
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Activation of swine peripheral blood lymphocytes with human recombinant interleukin-2.

Authors:  R C Bhagyam; D Jarrett-Zaczek; F G Ferguson
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

5.  Growth inhibition of Candida albicans by interleukin-2-activated splenocytes.

Authors:  D W Beno; H L Mathews
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.